A phase 3 study (Cosmic-313) of cabozantinib in combination with nivolumab and ipilimumab in patients with previously untreated advanced renal cell carcinoma of intermediate or poor risk Meeting Abstract
| Authors: | Choueiri, T.; Albiges, L.; Powles, T.; Mohamed, N.; Wang, F.; Motzer, R. |
| Abstract Title: | A phase 3 study (Cosmic-313) of cabozantinib in combination with nivolumab and ipilimumab in patients with previously untreated advanced renal cell carcinoma of intermediate or poor risk |
| Meeting Title: | 35th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) |
| Journal Title: | Journal for ImmunoTherapy of Cancer |
| Volume: | 8 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2020 Nov 9-14 |
| Meeting Location: | Virtual |
| ISSN: | 2051-1426 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2020-11-01 |
| Start Page: | A209 |
| Language: | English |
| ACCESSION: | WOS:000616665300332 |
| DOI: | 10.1136/jitc-2020-SITC2020.0342 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 342 -- Source: Wos |
